Changing How We Treat Relapsed/Refractory Hairy Cell Leukemia

Farhad Ravandi, MD, examines evolving new approaches to hairy cell leukemia, including the antibody-drug conjugate moxetumomab pasudotox, BRAF inhibitors, and combination regimens.
Farhad Ravandi, MD
Format: Microsoft PowerPoint (.ppt)
File Size: 1.67 MB
Released: April 24, 2019

Acknowledgements

Provided by Clinical Care Options, LLC

Clinical Care Options, LLC
12001 Sunrise Valley Drive
Suite 300
Reston, VA

Sophia Kelley
(203)-316-2125
skelley@clinicaloptions.com
www.clinicaloptions.com

Supported by an educational grant from
AstraZeneca

Related Content

John M. Burke, MD, and Shaji Kumar, MD, discuss practice-changing presentations in lymphomas, CLL, and multiple myeloma from ASCO 2019.

John M. Burke, MD Shaji Kumar, MD Physicians: maximum of 1.25 AMA PRA Category 1 Credits Released: August 16, 2019 Expiration: August 15, 2020

Noopur Raje, MD: Clinical impact of latest data for idecabtagene vicleucel (bb2121) and other CAR T-cells in relapsed/refractory multiple myeloma.

Noopur Raje, MD Physicians: maximum of 0.25 AMA PRA Category 1 Credits Registered Nurses: 0.25 Nursing contact hours Pharmacists: 0.25 contact hours (0.025 CEUs) Released: August 16, 2019 Expiration: August 15, 2020

Expert insights from Alessandra Tedeschi, MD, on new data for B-cell malignancy management reported at the 2019 EHA and ICML meetings

person default Alessandra Tedeschi, MD Physicians: maximum of 1.0 AMA PRA Category 1 Credit Released: August 13, 2019 Expiration: August 12, 2020

Elisabet E. Manasanch, MD, provides insights on the latest information on the treatment of patients with newly diagnosed myeloma

person default Elisabet E. Manasanch, MD Released: August 9, 2019

Leaving the CCO site

You are now leaving the CCO site. The new destination site may have different terms of use and privacy policy.

Continue

Welcome to the CCO site.

You are accessing CCO's educational content today as a Guest user.

If you would like to continue with free, full access to the CCO Web sites, including free CME/CE credits, please click the button below.

Continue

More info

CCO’s educational programs are available completely free of charge on the ClinicalOptions.com, inPractice.com, and inPracticeAfrica.com Web sites. Certain features and functions are restricted for Guest users. By consenting to become a full member, you are eligible to receive CME/CE credit or participation certificates from certified activities, to register for CCO’s free live meetings and webinars, and to receive CCO’s email newsletters alerting you to new content. You can unsubscribe from our emails at any time. CCO strictly protects the privacy of our members, according to our privacy policy.

A confirmation email will be sent to . Not You?